Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: Beijing Friendship Hospital
Condition: Biliary Tract Cancer, Anti-PD-1 Therapy, Targeted Molecular Therapy, Capecitabine
NCT04720131
Camrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer.
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Completed No Results Found Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
No stop reason available in the current public record.